BR112013000300A2 - comprimido que se desintegra intraoralmente - Google Patents

comprimido que se desintegra intraoralmente

Info

Publication number
BR112013000300A2
BR112013000300A2 BR112013000300A BR112013000300A BR112013000300A2 BR 112013000300 A2 BR112013000300 A2 BR 112013000300A2 BR 112013000300 A BR112013000300 A BR 112013000300A BR 112013000300 A BR112013000300 A BR 112013000300A BR 112013000300 A2 BR112013000300 A2 BR 112013000300A2
Authority
BR
Brazil
Prior art keywords
orally disintegrating
tablet
disintegrating tablet
intraorally
intraorally disintegrating
Prior art date
Application number
BR112013000300A
Other languages
English (en)
Inventor
Kazuhiro Nakamura
Teppei Ogawa
Original Assignee
Teijin Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teijin Pharma Ltd filed Critical Teijin Pharma Ltd
Publication of BR112013000300A2 publication Critical patent/BR112013000300A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)

Abstract

comprimido que se desintegra intraoralmente. é divulgado um cumprimido que se desintegra oralmente que disfarça o amargor, dissolve-se bem e que retém permanentemente boas propriedade de desintegração oral seguindo imediatamente a fabricação. o comprimido que se desintegra oralmente é formado pela moldagem por compressão de um ácido orgânico junto com as partículas que compreendem partículas nucleares contendo ingrediente ativo cobertos por uma camada contendo polímeros insolúveis em água e/ou polímeros entéricos.
BR112013000300A 2010-07-09 2011-07-08 comprimido que se desintegra intraoralmente BR112013000300A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2010156873 2010-07-09
PCT/JP2011/065714 WO2012005359A1 (ja) 2010-07-09 2011-07-08 口腔内崩壊錠剤

Publications (1)

Publication Number Publication Date
BR112013000300A2 true BR112013000300A2 (pt) 2016-05-31

Family

ID=45441335

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013000300A BR112013000300A2 (pt) 2010-07-09 2011-07-08 comprimido que se desintegra intraoralmente

Country Status (10)

Country Link
US (1) US20130115287A1 (pt)
EP (1) EP2591774B1 (pt)
JP (1) JP5697668B2 (pt)
KR (1) KR101828630B1 (pt)
CN (1) CN102958514B (pt)
AU (1) AU2011274845B2 (pt)
BR (1) BR112013000300A2 (pt)
CA (1) CA2804504C (pt)
MX (1) MX2013000284A (pt)
WO (1) WO2012005359A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160061773A1 (en) 2013-03-29 2016-03-03 Life Technologies Corporation Method for treating a semiconductor device
EP2612657B1 (en) * 2010-08-31 2023-08-09 Kyowa Kirin Co., Ltd. Orodispersible tablet
JP2017048174A (ja) * 2015-09-01 2017-03-09 大原薬品工業株式会社 化学的に安定な原薬含有被覆粒子を含む口腔内崩壊錠剤
WO2020091439A1 (ko) * 2018-10-31 2020-05-07 주식회사 삼양바이오팜 수니티닙을 함유하는 경구용 제제 및 그의 제조 방법
KR102308227B1 (ko) * 2018-10-31 2021-10-05 주식회사 삼양홀딩스 수니티닙을 함유하는 경구용 정제 조성물
KR102322429B1 (ko) * 2018-10-31 2021-11-08 주식회사 삼양홀딩스 수니티닙을 함유하는 경구용 제제 및 그의 제조 방법
WO2021125788A1 (ko) * 2019-12-17 2021-06-24 주식회사 삼양홀딩스 수니티닙 염산염을 포함하는 경구용 고형제제 및 그 제조 방법

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4151270A (en) * 1977-09-26 1979-04-24 Wm. Wrigley Jr. Company Chewing gum composition
EP0737473A1 (en) 1989-10-02 1996-10-16 Cima Labs, Inc. Effervescent dosage form
ES2559766T3 (es) * 1998-05-18 2016-02-15 Takeda Pharmaceutical Company Limited Comprimidos disgregables en la boca
FR2795962B1 (fr) * 1999-07-08 2003-05-09 Prographarm Laboratoires Procede de fabrication de granules enrobes a gout masque et liberation immediate du principe actif
US6264981B1 (en) 1999-10-27 2001-07-24 Anesta Corporation Oral transmucosal drug dosage using solid solution
JP4719899B2 (ja) * 2000-01-07 2011-07-06 大正製薬株式会社 口腔内速崩壊性錠剤
JP4886107B2 (ja) 2000-10-13 2012-02-29 サンスター株式会社 歯周病予防用口腔内溶解錠
ATE472319T1 (de) 2001-02-15 2010-07-15 Mitsubishi Tanabe Pharma Corp Tabletten, die in der mundhöhle schnell zerfallen
CN101836978B (zh) * 2002-03-28 2013-09-11 帝人制药株式会社 含有单一晶型的固体制剂
US8580305B2 (en) * 2003-01-21 2013-11-12 Tomoharu Suga Tablet quickly melting in oral cavity
US20060083786A1 (en) * 2004-07-29 2006-04-20 Glenmark Pharmaceuticals Limited Taste masking pharmaceutical composition containing levocetirizine
WO2006072832A1 (en) * 2005-01-07 2006-07-13 Pfizer Products Inc. Fast-disintegrating dosage forms of 5,8,14-triazatetracyclo[10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaene
CN1296042C (zh) * 2005-04-26 2007-01-24 北京科信必成医药科技发展有限公司 一种醋柳黄酮口腔崩解片及其制备方法
CN100374119C (zh) * 2005-09-21 2008-03-12 重庆康刻尔制药有限公司 三七皂苷口腔崩解片及其制备方法
PE20070698A1 (es) * 2005-11-14 2007-08-17 Teijin Pharma Ltd Comprimido de disgregacion rapida intraoral que contiene hidrocloruro de ambroxol
JP3884056B1 (ja) * 2006-01-27 2007-02-21 秋山錠剤株式会社 口腔内速崩錠の製造方法
EP2034953A4 (en) * 2006-06-26 2013-05-15 Capricorn Pharma Inc ORAL DISINTEGRATING LAYER COMPOSITIONS
WO2008027993A2 (en) * 2006-08-31 2008-03-06 Eurand, Inc. Drug delivery systems comprising solid solutions of weakly basic drugs
JP5405752B2 (ja) * 2007-01-31 2014-02-05 大日本住友製薬株式会社 被覆された薬物含有粒子および該粒子を含む固形製剤
EP2196221A4 (en) * 2007-09-27 2011-12-28 Mitsubishi Tanabe Pharma Corp SOLID PREPARATION WITH QUICK DISINTEGRATION
JP2009161495A (ja) * 2008-01-09 2009-07-23 Everest Pharm Industrial Co Ltd 緩慢に溶ける微粒のアスコルビン酸を含む一種の経口急速崩散錠。

Also Published As

Publication number Publication date
MX2013000284A (es) 2013-03-18
EP2591774B1 (en) 2020-05-27
EP2591774A1 (en) 2013-05-15
KR20130097091A (ko) 2013-09-02
KR101828630B1 (ko) 2018-02-12
CN102958514B (zh) 2016-08-31
AU2011274845A1 (en) 2013-01-24
US20130115287A1 (en) 2013-05-09
CA2804504A1 (en) 2012-01-12
AU2011274845B2 (en) 2015-07-30
WO2012005359A1 (ja) 2012-01-12
CN102958514A (zh) 2013-03-06
JP5697668B2 (ja) 2015-04-08
JPWO2012005359A1 (ja) 2013-09-05
EP2591774A4 (en) 2013-12-25
CA2804504C (en) 2018-08-21

Similar Documents

Publication Publication Date Title
BR112013000300A2 (pt) comprimido que se desintegra intraoralmente
EA201071204A1 (ru) Применение дронедарона для приготовления лекарственного средства для применения в предотвращении госпитализации в кардиологическое отделение или смертности
BRPI0820997A2 (pt) Comprimidos de desintegração oral compreendendo difenidramina.
IT1394401B1 (it) Sistema e procedimento per facilitare il trattamento e la produzione in un foro di pozzo.
GT201200332A (es) Composiciones sòlidas
TW201711676A (en) Ferric citrate dosage forms
CO6440531A2 (es) 2-acetamido-5-aril-1,2,4-triazolonas sustituidas y su uso
GT201200293A (es) Marcadores predictivos útiles en el tratamiento del síndrome frágil x (fxs)
HN2006009000A (es) Formas farmaceuticas con propiedades farmacocineticas mejoradas
EA201071378A1 (ru) Дронедарон для предотвращения постоянной фибрилляции предсердий
BR112012032008A2 (pt) anticorpos s100a4 e usos terapêuticos do mesmo
IT1394876B1 (it) "mezzi per la duplicazione di una chiave codificata elettronicamente e relativo procedimento di duplicazione"
USD693716S1 (en) Laser distance measurement device
USD650833S1 (en) Typeface
NI201100149A (es) Derivados de tiadiazoles y oxadiazoles, su preparación y su aplicación en terapia.
BR112012027794A2 (pt) tablete entérico
MX2012001691A (es) Composiciones de linaclotida que se desintegran oralmente.
EA201200485A1 (ru) Перорально распадающаяся фармацевтическая лекарственная форма, содержащая арипипразол
WO2011142731A3 (en) Formulations comprising a third generation cephalosporin and clavulanic acid
MA32461B1 (fr) Dronedarone pour la prevention de cardioversion
MX2015012970A (es) Formas de dosificacion solidas de liberacion prolongada antiemeticas.
BRPI1016020A2 (pt) linha cirúrgica que compreende células e método de produção da linha.
IT1402643B1 (it) Corpo per pedale strumentato e procedimento di produzione dello stesso.
MX2015006011A (es) Pastilla medicinal a base de ibuprofeno sodico dihidratado.
WO2012018742A3 (en) Dextromethorphan antitussive compositions

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06T Formal requirements before examination [chapter 6.20 patent gazette]
B11E Dismissal acc. art. 34 of ipl - requirements for examination incomplete
B11T Dismissal of application maintained [chapter 11.20 patent gazette]